There’s a new boss, as well as other changes at the top of the org chart, at Lonza Biologics as the Portsmouth pharmaceuticals manufacturer enters a new phase of growth and expansion. The new boss, ...

China has eased its drug regulations in hopes of drawing some of the new meds for which its citizens are clamoring. Swiss CDMO Lonza is joining a rush of companies looking to cash in on the situation ...

Narrow-moat Lonza provided a first-quarter 2024 qualitative update, and the company is tracking our expectations. Management will release additional details when it reports its half-yearly results in ...

Lonza said today it will expand its mid-scale biologics manufacturing capacity as part of an expansion of its Portsmouth, NH, site set to begin later this year. The cost of the expansion was not ...

PORTSMOUTH -- Lonza Biologics intends to add 32,300 square feet of additional manufacturing space and 250 new jobs to its plant at the Pease International Tradeport. The company Thursday morning ...

Wednesday, Roche Holding AG (OTC:RHHBY) entered into a definitive agreement with Lonza Group Ltd (OTC:LZAGF) (OTC:LZAGY). Under the agreement, Lonza will acquire the Genentech manufacturing facility ...

Teva to Pursue Its Biologics Strategy to Create a Balanced Portfolio of Biosimilars, Biobetters and Innovative Biologics. Lonza to Focus on Core Expertise in Contract Manufacturing and Cell Line ...

Lonza LONN trimmed its 2023 outlook to mid- to high-single-digit sales growth (from high single digits) and 28%-29% core EBITDA margin, due to slower growth in early-stage services and a decrease in ...

PORTSMOUTH — For its part on the supply side to satisfy demand for the COVID-19 vaccine, Lonza Biologics says it is working at capacity to satisfy its current production agreement with Moderna. “We ...

Moderna Inc.’s CEO now says the company’s eagerly awaited Covid-19 vaccine won’t be ready until November – after the election – but as soon as it is set, a key part of production will begin almost ...

Lonza Group announced Monday morning that Pierre-Alain Ruffieux will leave his post as CEO at the end of the month. Ruffieux, a former Roche executive, joined Lonza in 2020 and oversaw the company’s ...

Swiss CDMO Lonza is extending the Chinese New Year break at its four plants in China, but not to celebrate. The unplanned extension is a precaution as coronavirus continues to spread rapidly through ...